VKH
LXRX icon

Virtu KCG Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

Virtu KCG Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,317
Closed -$205K – 3237
2017
Q1 		$205K Sell
14,317
-23,517
-62% -$349K 0.01% 2391
2016
Q4 		$523K Buy
37,834
+17,022
+82% +$273K 0.01% 1444
2016
Q3 		$376K Buy
+20,812
New +$335K 0.01% 1680
2015
Q2 		– Sell
-4,851
Closed -$32K – 3570
2015
Q1 		$32K Sell
4,851
-3,037
-39% -$20.7K ﹤0.01% 2893
2014
Q4 		$50K Buy
+7,888
New +$63.6K ﹤0.01% 3440
2014
Q2 		– Sell
-1,503
Closed -$18K – 3892
2014
Q1 		$18K Sell
1,503
-4,258
-74% -$54.4K ﹤0.01% 3437
2013
Q4 		$72K Sell
5,761
-329
-5% -$5.23K ﹤0.01% 3528
2013
Q3 		$101K Buy
+6,090
New +$102K ﹤0.01% 3363

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu KCG Holdings's LXRX Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2017, closing a stake of 14,317 shares — an estimated $205K sold.

Virtu KCG Holdings first reported a position in LXRX in Q3 2013 and held it in 8 quarters. The position peaked at $523K in Q4 2016. 135 funds tracked by Wall St. Rank hold LXRX as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Lexicon Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 14,317 Lexicon Pharmaceuticals shares in Q2 2017, an estimated $205K.
  • Virtu KCG Holdings first reported a position in Lexicon Pharmaceuticals in Q3 2013 and held it in 8 quarters.
  • Virtu KCG Holdings's Lexicon Pharmaceuticals position peaked at $523K in Q4 2016.
  • 135 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.